Dr Peters current work is focused on use of different antihypertensives, frailty and risk and benefit of treatment in the very elderly.
Between 2010 and 2012 Dr Peters was part of the core team setting up and developing the Imperial Clinical Trials Unit (ICTU). ICTU was launched in 2010 and is a fully UKCRC registered trials unit.
Prior to 2010 she led the multinational HYpertension in the Very Elderly Trial Cognitve function (HYVET-COG) study and co-ordinated the main Hypertension in the Very Elderly [HYVET] trial. HYVET was an Imperial sponsored multinational double blind RCT which was rated ‘Trial of the year’ by the Society for Clinical Trials and an exceptional landmark in medicine(F1000) in 2008. The HYVET trial results have changed global guidelines for the use of antihypertensive treatment in older adults (>=80 years).
Research interests include risk factors for dementia, particularly cardiovascular risk factors and potential interventions to ameliorate or prevent cognitive decline and dementia.
et al., 2020, Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysis., Ann Intern Med
Maccora J, Peters R, Anstey KJ, 2020, What does (low) education mean in terms of dementia risk?: a systematic review and meta-analysis highlighting inconsistency in measuring and operationalising education, Ssm - Population Health, ISSN:2352-8273, Pages:100654-100654
et al., 2020, Atrial fibrillation and the risk of cardiovascular disease and mortality in the Hypertension in the Very Elderly Trial, Journal of Hypertension, Vol:38, ISSN:0263-6352, Pages:839-844
Maccora J, Peters R, Anstey KJ, 2020, Gender differences in superior-memory SuperAgers and associated factors in an Australian cohort, Journal of Applied Gerontology, ISSN:0733-4648
et al., 2020, Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis, Neurology, Vol:94, ISSN:0028-3878, Pages:E267-E281